Leuprolide Terminated Phase 3 Trials for Prostate Cancer Supportive Care

IndicationsStatusPurposePhase
TerminatedSupportive Care3
clinicaltrials.gov IdentifierTitleDrugs
NCT00630799Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients